Narwhal Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-32,700
Closed -$2.45M 135
2016
Q1
$2.45M Hold
32,700
0.8% 42
2015
Q4
$2.52M Sell
32,700
-6,650
-17% -$501K 0.87% 39
2015
Q3
$2.63M Sell
39,350
-225
-0.6% -$16.6K 0.98% 32
2015
Q2
$2.93M Buy
39,575
+400
+1% +$30.6K 1.07% 27
2015
Q1
$3.06M Buy
+39,175
New +$2.97M 1.12% 24
2014
Q4
Sell
-41,750
Closed -$2.59M 138
2014
Q3
$2.59M Hold
41,750
1.04% 25
2014
Q2
$2.66M Buy
41,750
+300
+0.7% +$18.2K 1.02% 27
2014
Q1
$2.55M Buy
41,450
+600
+1% +$35K 1.06% 24
2013
Q4
$2.34M Sell
40,850
-50
-0.1% -$2.83K 0.97% 24
2013
Q3
$2.18M Buy
40,900
+2,000
+5% +$108K 1.04% 24
2013
Q2
$2M Buy
+38,900
New +$1.92M 0.97% 32

Other funds holding MDT

Narwhal Capital Management's MDT Position: Q2 2016 in Review

Narwhal Capital Management sold out of Medtronic (MDT) in Q2 2016, closing a stake of 32,700 shares — an estimated $2.45M sold.

Narwhal Capital Management first reported a position in MDT in Q2 2013 and held it in 11 quarters. The position peaked at $3.06M in Q1 2015. 1,262 funds tracked by Wall St. Rank hold MDT as of Q2 2016.

  • Narwhal Capital Management reported no remaining Medtronic position as of Q2 2016 after selling out during the quarter.
  • Narwhal Capital Management sold 32,700 Medtronic shares in Q2 2016, an estimated $2.45M.
  • Narwhal Capital Management first reported a position in Medtronic in Q2 2013 and held it in 11 quarters.
  • Narwhal Capital Management's Medtronic position peaked at $3.06M in Q1 2015.
  • 1,262 funds tracked by Wall St. Rank held Medtronic as of Q2 2016.

Based on Narwhal Capital Management's 13F filing for Q2 2016, filed 26 Jul 2016.